Description
Dr. Alastair Carruthers is a Cosmetic Dermatologic surgeon, and Clinical Professor of Dermatology with the Faculty of Medicine at the University of British Columbia (UBC). During his 20 years of practice, Dr. Carruthers has made several major contributions to the field of dermatology. Foremost among these was the use of the BOTOX procedure in cosmetic applications, a discovery he made with his wife, Dr. Jean Carruthers, in 1987. Since this time, they have been at the forefront of BOTOX research, development and education, publishing numerous articles using their data. Dr. Carruthers has also made significant advances in the area of Tissue Augmentation. These materials, both temporary and permanent, are used to lift and support the structures beneath the skin. In 1998 Dr. Carruthers was the first dermatologist in North America to begin injecting Artecoll. Dr. Carruthers has over 100 published articles to his credit and has also contributed extensively to studies about the relationship between skin cancer and sun exposure. Part 1: Basic Science and Clinical Usage of Neuromodulators 1. Newer Non-Cosmetic Uses of the Botulinum Toxins (former name: Therapeutic Uses of the Botulinum Toxins) 2. History of Cosmetic Botulinum Toxin 3. Pharmacology of BOTOX Cosmetic 4. Abobotulinum Toxin A: Science and Clinical Usage 5. Basic Science: Xeomin 6. Prabotulinum toxin A 7. Basic Science: Myobloc 8. Basic Science of Botulinum Toxin E 9. Neuronox, Innotox, and Coretox 10. Injectable DaxibotulinumtoxinA (RT002) 11. Comparison of Botulinum Toxins 12. Topical Botulinum Toxin Type A 13. Reconstitution / Dilution 14. Benzyl Alcohol Part 2: Neuromodulator Injection Sites 15. Treatment of Glabellar Lines with Neuromodulators 16. Treatment of Frontalis and Horizontal Forehead Lines with Neuromodulators 17. Shaping the Eyebrow and Upper Face (Palpebral Aperture) with Neuromodulators and Fillers 18. Treatment of Crow’s Feet with Neuromodulators 19. Treatment of Infraorbital / Upper and Lower Eyelids with Neuromodulators 20. Treatment of the Mid-face with Botulinum Toxin (e.g. nasal tip, rosacea) 21. Treatment of Orbicularis Oris, Mentalis, Depressor Anguli Oris (e.g. Lip Lines) with Neuromodulators 22. Platysma, Nefertiti Lift and Beyond (e.g. Chest) 23. The Masseters and Their Treatment with Botulinum Toxin 24. Treatment of Darker Skin Types with Neuromodulators 25. Combination Noninvasive Facial Aesthetic Treatments with Botulinum Toxin Type A 26. Treatment of Focal Axillary Hyperhidrosis with Neuromodulators (and Scalp and Inguinal) 27. Treatment of Palmo-Plantar Hyperhidrosis with Neuromodulators Part 3: Future Directions for Aesthetic Neuromodulators 28. The Future of Neuromodulators in Aesthetic Medicine 29. Neuromodulator Immunogenicity
